why are glp 1 meds so expensive Perspectives from employers on the costs and issues associated with covering GLP-1 agonists for weight loss Addressing GLP-1 Access and Adherence
Description
Semaglutide (Ozempic, Wegovy, Rybelsus) : Available as once-weekly injection (0.52.0 mg for diabetes
For heart failure or chronic kidney disease, the American Diabetes Association generally recommends SGLT2 inhibitors as first-line agents, with GLP-1 receptor agonists considered for their benefits on atherosclerotic cardiovascular disease, glycemic control, and weight management, or when SGLT2 inhibitors are not appropriate
Abbreviations: CI, confidence interval
Otherwise, they will receive a quote
what should I do
